DermTopic: Skin Cancer
News
DermWireTV: Medical Derm at Summer AAD; Novel Drugs, Acne at…
The Summer meeting of the American Academy of Dermatology (AAD) gathers members for updates on medical and aesthetic adv…
DermWire.com
DermWireTV: Skin Cancer Awareness, Epiduo Data, Impoyz Launc…
Data shed light on patents’ attitudes towards kids’ sunblock and new findings emerge on melanoma risks. FDA accepts …
DermWire.com
DermWireTV: Indiana Gets SUNucated, Dr. Joel Cohen Honored, …
Indiana is the first state in 2018 to give children broader access to sunscreen at school through the SUNucation Initiat…
DermWire.com
DermWireTV: Summer AAD NYC Updates; Modernizing Medicine Gro…
As in years past, the summer meeting of the AAD has focused attention on optimal uses for both existing and emerging the…
DermWire.com
DermWireTV: Sunscreen Ratings, Long Live Skin Launches, SCAL…
Consumer Reports says that one-third of sunscreens tested in its latest evaluation provided less than half of the SPF pr…
DermWire.com
DermWireTV: Skin Cancer Prevention, Mohs Data, Allergan Clos…
It's Skin Cancer Awareness Month. Joel L. Cohen, MD and Shadi Kourosh, MD share tips on patient education and skin prote…
DermWire.com
DermWireTV: AAD and Week of Science, ADCETRIS CTCL Data, SIL…
It's the Week of Science. The American Academy of Dermatology has joined a large group of other medical group in support…
DermWire.com
UV Talk: Men and Women
Talk to every patient about UV avoidance, but tailor your patient to each patient's needs and behavior, says Joel L. Coh…
UV Talk: Spread the Message
The public isn't getting the UV protection message. They need to use the right sunscreens with the right ingredients, an…
Joel L. Cohen, MD, FAAD
DermWireTV: Dupixent, Juvéderm Vollure XC, Bavencio Approva…
The FDA has approved Regeneron’s injectable Dupixent (dupilumab) to treat adults with moderate-to-severe eczema. It wi…
DermWire.com
DermWireTV: Valeant's Siliq Cleared, AmSpa Survey, New Skin …
The FDA has approved Valeant Pharmaceutical's Siliq (brodalumab) injection for subcutaneous use for patients with modera…
DermWire.com
Build a Better Relationship with Your Dermatopathologist
A strong relationship between the dermatologist and dermatopathologist is essential in achieving the best diagnosis for …
Abel Jarell, MD, Joel L. Cohen, MD
Beyond SPF: Protecting the Skin
In addition to protecting the skin from sun damage, it’s becoming increasingly important to consider pollution’s rol…
Arianne Shadi Kourosh, MD, Rebecca Kazin, MD
DermWireTV: L'Oreal Nabs CeraVe, Smart Beauty Tools, Skin Ca…
Researchers from La Roche-Posay and the George Washington University Department of Dermatology find that citizens in Aus…
DermWire.com
CSF 2016 Highlights from the Founder
Cosmetic Surgery Forum Founder and Practical Dermatology® Chief Surgical Editor Joel Schlessinger, MD talks about CSF 2…
Joel Schlessinger, MD
DermWireTV: Updates on NMSC, Zika, Aesthetics from Summer AA…
From the dermatologist’s role in preparing for Zika to the latest advancements in aesthetics, the Summer meeting of th…
DermWire.com
AK Pearls: Managing Treatment Reactions
Dr. Bhatia shares pearls for managing side effects and reactions to actinic keratosis treatment drugs. There are many ad…
Neal Bhatia, MD, FAAD, Seemal R. Desai, MD
Advances in Treating NMSC
Dr. Goldenberg discusses the benefits of timed sequential therapy using two modalities — destructive therapy followed …
Gary Goldenberg, MD, Seemal R. Desai, MD
Pearls from NYC: Oy Vey!
By Gary Goldenberg, MD and Seemal R. Desai, MDWhat happens if you shave a melanoma? Dr. Goldenberg addresses a common qu…
Gary Goldenberg, MD, Seemal R. Desai, MD
Advanced Systemic Therapeutics
By Seemal R. Desai, MD and Neal Bhatia, MD, FAADFrom updates in infectious disease to hormonal therapies, and off-label …
Neal Bhatia, MD, FAAD, Seemal R. Desai, MD
Getting the Upper Hand on NMSC
By Seemal R. Desai, MD and Anthony Rossi, MDDecide what type of treatment to use to treat the specific, biopsy-confirmed…
Anthony Rossi, MD, Seemal R. Desai, MD
DermWireTV: Robert Grant Steps Down at Alphaeon; Skin Cancer…
Robert Grant is no longer CEO of lifestyle healthcare company Alphaeon. Mr. Grant founded Alphaeon in 2013 as a wholly o…
DermWire.com
Wondering with Steve and Sabrina: Mexico
Traveling in the Baja Desert, Steven Dayan, MD and Sabrina Fabi, MD discover the benefits of Lomboy, a plant that can be…
Sabrina Fabi, MD, Sabrina G. Fabi, MD, Steven Dayan, MD, Steven Dayan, MD, Steven Dayan, MD
New Treatment Algorithms for Actinic Keratoses
Gary Goldenberg, MD reviews the literature showing why all actinic keratoses (AKs) need to be treated and why it’s imp…
Gary Goldenberg, MD, Joel L. Cohen, MD, FAAD
Chemoprevention Strategies for AK Patients
Neal Bhatia, MD, Chief Medical Editor of Practical Dermatology®, provides strategies for treating actinic keratoses, as…
Joel L. Cohen, MD, Neal Bhatia, MD, FAAD
Cutaneous Oncology
Maui Derm Course Director George Martin, MD, recaps the discussion from the Cutaneous Oncology session during Maui Derm …
George Martin, MD, Seemal Desai, MD
An Off-Label Adjuvant Treatment for Melanoma
In part two of DermTube Journal Club Host Dr. Joshua Zeichner’s interview with Murad Alam, MD, they talk about the rol…
Joshua Zeichner, MD, FAAD, Murad Alam, MD
DermWireTV: BONT-A Extends Fillers; Almirall to Acquire Ther…
In this edition of DermWireTV, a look at new data showing that injections with botulinum neurotoxin can extend the effic…
DermWire.com
Advances in Reconstructive Surgery
Murad Alam, MD, talks to DermTube Journal Club Host Joshua Zeichner, MD about what's new in reconstructive surgery. Dr. …
Joshua Zeichner, MD, FAAD, Murad Alam, MD
DermWireTV: Valeant Business Update; Melanoma Drugs Approved
In this edition of DermWireTV from the editors of Practical Dermatology® magazine and DermWire.com, we take a look at V…
DermWire.com
Mohs Certification: Finding a Middle Ground
Can specialists reach a consensus on Mohs certification? Joel Schlessinger, MD, FAAD certainly hopes so. He spoke with D…
Joel Schlessinger, MD
Superficial Radiation for Keloids: SRT-100 in Practice
Keloids are common. Certain patients, especially patients of color, are more prone to the development of keloids in cert…
Mark S. Nestor, MD, PhD
DermWireTV: Cellfina Cleared, Finacea Foam Approved
The FDA has cleared Cellfina (Ulthera Inc./Merz Aesthetics, Inc.) to treat cellulite, with results lasting for up to 2 y…
DermWire.com
DermWireTV: Vanquish Approved for Circumferential Fat Reduct…
BTL's Vanquish Cleared for Circumferential Fat Reduction of the Abdomen, Filler Injections Gain Popularity Off the Face,…
DermWire.com
DermWireTV: ASDS BCC Recommendations; Bad Online Reviews for…
This edition of DermWireTV, from the editors of Practical Dermatology® magazine reviews the new ASDS Consensus Recommen…
DermWire.com
The State of Dermatology Entrepreneurship 2015
William Ju, MD, President of Advancing Innovation in Dermatology talks about entrepreneurship in dermatology. Where are …
William Ju, MD, Advancing Innovation in Dermatology
Skin cancer: Coach's toughest opponent [Full-length]
Dr. Terrence Keaney created this PSA for his American Society for Dermatologic Surgery (ASDS) Future Leaders Network pro…
Skin cancer: Coach's toughest opponent: PSA
Dr. Terrence Keaney created this PSA for his American Society for Dermatologic Surgery (ASDS) Future Leaders Network pro…
Guys Don't Be Like Paul
Dr. Terrence Keaney created this PSA for his American Society for Dermatologic Surgery (ASDS) Future Leaders Network pro…
Guys, Don't Be Like Paul:Â PSA
Dr. Terrence Keaney created this PSA for his American Society for Dermatologic Surgery (ASDS) Future Leaders Network pro…
Ask An Expert: Establishing Yourself as an Expert
In this edition of NewDermMD's video series, host Adam Friedman, MD speaks with Neal Bhatia, MD about establishing one's…
Adam Friedman, MD, Neal Bhatia, MD, FAAD
DermWireTV: Panel Supports ATX-101; Melanoma Metastasis Test
An FDA Advisory Panel Backs Kythera's ATX-101 for (Submental Fullness) or Double Chin, and a new genetic analysis may en…
DermWire.com
What's New in Dermatopathology
Joshua Zeichner, MD speaks with Clay Cockerell, MD about the latest developments in dermatopathology. Specifically, Dr. …
Clay Cockerell, MD, Joshua Zeichner, MD, FAAD
2014 Year in Review: Skin Cancer
Gary Goldenberg, MD offers a snapshot look at the newest therapies in the skin cancer treatment landscape, as well as th…
Gary Goldenberg, MD
2014 Year in Review: Actinic Keratosis
Neal Bhatia, MD discusses the management of actinic keratosis in 2014. He also offers a look at what’s ahead for the s…
Neal Bhatia, MD, FAAD
DermWireTV: Allergan Strikes $66 Billion Deal with Actavis
In this edition of DermWireTV, host Ranna Jaraha discusses this week’s blockbuster merger deal between Allergan and Ac…
DermWireTV: FDA Approves New Melanoma Treatment with Novel M…
Merck's Keytruda, a novel PD-1 inhibitor, is approved for advanced melanoma, and a topical mole remover is being recalle…
Devyn Gehret
Antioxidants and Sunscreens
Jennifer Linder, MD, FAAD explains the science behind antioxidants in sunscreens and discusses the benefits of using ant…
Jennifer Linder, MD, FAAD
Update on Melanoma Detection and Screening
From full body skin exams to emerging tape-strip methods for melanoma diagnosis, Laura Ferris, MD talks about the latest…
Joshua Zeichner, MD, FAAD, Laura Ferris, MD
Controversies in Mohs Surgery
Joel Schlessinger, MD discusses the changing landscape of Mohs surgery for skin cancer. Specifically he addresses turf w…
